Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of the Novel Therapies for Metastatic Urothelial Carcinoma. Issue 30 (20th October 2021)

Record Type:
Journal Article
Title:
Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of the Novel Therapies for Metastatic Urothelial Carcinoma. Issue 30 (20th October 2021)
Main Title:
Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of the Novel Therapies for Metastatic Urothelial Carcinoma
Authors:
Powles, Thomas
Petrylak, Daniel P.
Rosenberg, Jonathan E.
Abstract:
Is Part Of:
Journal of clinical oncology. Volume 39:Issue 30(2021)
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 30(2021)
Issue Display:
Volume 39, Issue 30 (2021)
Year:
2021
Volume:
39
Issue:
30
Issue Sort Value:
2021-0039-0030-0000
Page Start:
3411
Page End:
3412
Publication Date:
2021-10-20
Subjects:
Oncology -- Periodicals
Cancer -- Periodicals
Oncology
Medical Oncology
Cancérologie -- Périodiques
Cancer -- Périodiques
Cancérologie
Cancer
Oncology
Oncologia
Càncer
Periodicals
616.994
Journal URLs:
http://www.jco.org/ ↗
http://jco.ascopubs.org/ ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:
10.1200/JCO.21.01430 ↗
Languages:
English
ISSNs:
0732-183X
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
21450.xml